Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0193 Transporter Info
Gene Name	SLC25A31
Transporter Name	Adenine nucleotide translocator 4
Gene ID	83447
UniProt ID	Q9H0C2

Post-Translational Modification of This DT
Overview of SLC25A31 Modification Sites with Functional and Structural Information
Sequence	M H R E P A K K K A E K R L F D A S S F G K D L L A G G V A A A V S K T A V A P I E R V K L L L Q V Q A S S K Q I S P E A R Y K G M V D C L V R I P R E Q G F F S F W R G N L A N V I R Y F P T Q A L N F A F K D K Y K Q L F M S G V N K E K Q F W R W F L A N L A S G G A A G A T S L C V V Y P L D F A R T R L G V D I G K G P E E R Q F K G L G D C I M K I A K S D G I A G L Y Q G F G V S V Q G I I V Y R A S Y F G A Y D T V K G L L P K P K K T P F L V S F F I A Q V V T T C S G I L S Y P F D T V R R R M M M Q S G E A K R Q Y K G T L D C F V K I Y Q H E G I S S F F R G A F S N V L R G T G G A L V L V L Y D K I K E F F H I D I G G R
PTM type	X-Acetylation X-Oxidation X-Phosphorylation X-Ubiquitination X: Amino Acid

Acetylation
Lysine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A31			[1]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	104
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A31 Lysine 104 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A31			[2]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	106
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A31 Lysine 106 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC25A31			[3]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	218
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A31 Lysine 218 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC25A31			[4]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	219
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A31 Lysine 219 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC25A31			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	270
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A31 Lysine 270 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC25A31			[5]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	303
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC25A31 Lysine 303 has the potential to affect its expression or activity.
Oxidation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A31			[6]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	235
Experimental Method	Co-Immunoprecipitation
Detailed Description	Oxidation at SLC25A31 Cystine 235 has the potential to affect its expression or activity.
Phosphorylation
Serine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A31			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Serine 18 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A31			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	19
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Serine 19 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC25A31			[7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	34
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Serine 34 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC25A31			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	53
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Serine 53 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC25A31			[8] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Serine 54 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC25A31			[10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	58
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Serine 58 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC25A31			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	113
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Serine 113 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC25A31			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Serine 279 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A31			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	36
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Threonine 36 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A31			[16] , [17]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	96
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Threonine 96 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC25A31			[18]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	220
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Threonine 220 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A31			[17] , [19]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	93
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC25A31 Tyrosine 93 has the potential to affect its expression or activity.
Ubiquitination
Lysine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC25A31			[11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	45
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A31 Lysine 45 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC25A31			[11] , [20]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	104
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A31 Lysine 104 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC25A31			[11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	106
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A31 Lysine 106 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC25A31			[11]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	108
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC25A31 Lysine 108 has the potential to affect its expression or activity.

References
1	Enigma or expert?. Nurs Mirror. 1983 Jan 26;156(4):46.
2	Percutaneous, radiographically guided biopsy: a history. Radiology. 1995 Aug;196(2):329-33.
3	Mechanism of cell infection with hepatitis C virus (HCV)--a new paradigm in virus-cell interaction. Pol J Microbiol. 2009;58(2):93-8.
4	Optimization of process parameters for maximum poly(-beta-)hydroxybutyrate (PHB) production by Bacillus thuringiensis IAM 12077. Pol J Microbiol. 2009;58(2):149-54.
5	Insights into the lysine acetylproteome of human sperm. J Proteomics. 2014 Sep 23;109:199-211.
6	Comparative proteomic analysis of cysteine oxidation in colorectal cancer patients. Mol Cells. 2013 Jun;35(6):533-42.
7	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
8	Phosphoproteomic and Functional Analyses Reveal Sperm-specific Protein Changes Downstream of Kappa Opioid Receptor in Human Spermatozoa. Mol Cell Proteomics. 2019 Mar 15;18(Suppl 1):S118-S131.
9	Quantitative phosphoproteomics analysis reveals a key role of insulin growth factor 1 receptor (IGF1R) tyrosine kinase in human sperm capacitation. Mol Cell Proteomics. 2015 Apr;14(4):1104-12.
10	The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science. 2011 Jun 10;332(6035):1317-22.
11	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
12	Temporal profiling of lapatinib-suppressed phosphorylation signals in EGFR/HER2 pathways. Mol Cell Proteomics. 2012 Dec;11(12):1741-57.
13	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
14	The Plk1-dependent phosphoproteome of the early mitotic spindle. Mol Cell Proteomics. 2011 Jan;10(1):M110.004457.
15	Quantitative phosphoproteomics identifies substrates and functional modules of Aurora and Polo-like kinase activities in mitotic cells. Sci Signal. 2011 Jun 28;4(179):rs5.
16	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
17	Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
18	iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
19	Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma. Nat Commun. 2018 Nov 21;9(1):4904.
20	Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics. Nat Struct Mol Biol. 2020 Feb;27(2):210-220.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence